Plus Therapeutics(PSTV)

Search documents
Plus Therapeutics (PSTV) Investor Presentation - Slideshow
2021-03-18 19:53
Corporate Presentation February 2021 1 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement in this document that is not a historical fact is a "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," " ...
Plus Therapeutics(PSTV) - 2020 Q4 - Earnings Call Transcript
2021-02-23 02:10
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2020 Earnings Conference Call February 22, 2021 5:00 PM ET Company Participants Marc Hedrick - President and CEO Andrew Sims - CFO Conference Call Participants Emad Samad - Octaviant Ed Woo - Ascendiant Capital Operator Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Fourth Quarter and Full year 2020 Results Call. At this time, all participants have been placed in a listen-only mode, and the floor will be opened for your questions following the ...
Plus Therapeutics(PSTV) - 2020 Q4 - Annual Report
2021-02-21 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-34375 PLUS THERAPEUTICS, INC. (previously known as Cytori Therapeutics, Inc.) (Exact name of Registrant as Specified in Its Charter) ...
Plus Therapeutics (PSTV) Investor Presentation - Slideshow
2021-01-16 00:49
Corporate Presentation January 2021 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement in this document that is not a historical fact is a "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "may ...
Plus Therapeutics(PSTV) - 2020 Q3 - Earnings Call Transcript
2020-10-23 01:17
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2020 Earnings Conference Call October 22, 2020 5:00 PM ET Company Participants Marc Hedrick - President and Chief Executive Officer Andrew Sims - Chief Financial Officer Conference Call Participants Jason McCarthy - Maxim Group Ed Woo - Ascendiant Capital Sean Lee - H.C. Wainwright Operator Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Third Quarter 2020 Earnings Results Call. At this time, all participants have been placed in a listen-only m ...
Plus Therapeutics(PSTV) - 2020 Q2 - Earnings Call Transcript
2020-08-11 02:15
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q2 2020 Earnings Conference Call August 10, 2020 5:00 PM ET Company Participants Marc Hedrick - President and CEO Andrew Sims - CFO Conference Call Participants Robert LeBoyer - Ladenburg Thalmann Ed Woo - Ascendiant Capital Emad Samad - WBB Operator Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Second Quarter 2020 Earnings Results Call. At this time, all participants have been placed in a listen-only mode, and the floor will be open for your qu ...
Plus Therapeutics(PSTV) - 2020 Q1 - Earnings Call Transcript
2020-05-15 02:55
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q1 2020 Results Conference Call May 14, 2020 5:00 PM ET Company Participants Marc Hedrick - President and CEO Andrew Sims - CFO Conference Call Participants Anita Dushyanth - Zacks Investment Ed Woo - Ascendiant Capital Operator Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics First Quarter 2020 Earnings Results Call. At this time, all participants have been placed in a listen-only mode, and the floor will be open for questions following the presen ...
Plus Therapeutics(PSTV) - 2019 Q4 - Earnings Call Transcript
2020-03-31 02:05
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2019 Results Conference Call March 30, 2020 5:00 PM ET Company Participants Dr. Marc Hedrick - President and CEO Andrew Sims - CFO Conference Call Participants Ed Woo - Ascendiant Operator Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Fourth Quarter and Full Year 2019 Earnings Results Call. At this time, all participants have been placed in a listen-only mode, and the floor will be open for questions following the presentation. [Operator Inst ...
Plus Therapeutics (PSTV) Presents At Biotech Showcase 2020 - Slideshow
2020-01-15 20:27
Delivering More For Patients Positively Impacting Healthcare Marc Hedrick, MD President & CEO Nasdaq: PSTV Biotech Showcase January 14, 2020 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on our management's current beliefs, expectations and assumptions about future events, conditions and results and on information currently available to us. All statements, other than stat ...
Plus Therapeutics(PSTV) - 2019 Q3 - Earnings Call Transcript
2019-11-15 01:48
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2019 Earnings Conference Call November 14, 2019 5:00 PM ET Company Participants Dr. Marc Hedrick - President and Chief Executive Officer Desiree Smith - Corporate Controller and Principal Accounting Officer Conference Call Participants Emad Samad - WBB Operator Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Investor Conference Call. At this time, all participants have been placed in a listen-only mode and the floor will be open for questions f ...